Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Return on Capital Employed (2016 - 2025)

Nephros has reported Return on Capital Employed over the past 15 years, most recently at 0.11% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.11% for Q4 2025, up 11.0% from a year ago — trailing twelve months through Dec 2025 was 0.11% (up 11.0% YoY), and the annual figure for FY2025 was 0.12%, up 12.0%.
  • Return on Capital Employed for Q4 2025 was 0.11% at Nephros, down from 0.14% in the prior quarter.
  • Over the last five years, Return on Capital Employed for NEPH hit a ceiling of 0.14% in Q3 2025 and a floor of 0.44% in Q4 2022.
  • Median Return on Capital Employed over the past 5 years was 0.21% (2021), compared with a mean of 0.16%.
  • Biggest five-year swings in Return on Capital Employed: decreased -21bps in 2022 and later rose 28bps in 2025.
  • Nephros' Return on Capital Employed stood at 0.24% in 2021, then tumbled by -86bps to 0.44% in 2022, then skyrocketed by 61bps to 0.17% in 2023, then soared by 100bps to 0.0% in 2024, then soared by 16422bps to 0.11% in 2025.
  • The last three reported values for Return on Capital Employed were 0.11% (Q4 2025), 0.14% (Q3 2025), and 0.13% (Q2 2025) per Business Quant data.